Will Merck’s Gardasil HPV Vaccine be its Next Vioxx?

Richard Gale
Opednews.com

05/26/2010

Do you find something seriously wrong with this scenario?

Reports of faulty gas pedals, obstructive floor carpets, and failing breaks in Toyota and Lexus vehicles generated uproar across major media networks. For the 4-year period starting in 2006, the National Highway Traffic Safety Administration (NHTSA) had reported 5 deaths, 17 injuries and 13 crashes, and an additional 29 deaths between 2000 and 2005. There was no hesitation among the networks and federal officials to demonize Toyota for knowingly risking the lives of people solely to empty its dealership lots. Even Congress quickly called for a Congressional investigation, and Toyota took upon itself the responsibility to recall over 8 million vehicles.

During the same four year period while NHTSA was collecting crash data on Toyota’s lemons, the Centers for Disease Control’s (CDC) Vaccine Adverse Events Reporting System (VAERS) database was gathering casualty data following vaccinations with Merck’s human papilloma virus (HPV) vaccine, Gardasil. And it was clear that Merck was far ahead and winning its race against Toyota for the Lemon of the Decade Award. Since Gardasil’s launch in 2006, the vaccine has been responsible for 66 deaths and over 17,700 medical injuries of young girls, some as young as 11 years old. Six percent of reported events, or 1,100 girls, were serious enough to require emergency hospitalization.

Read the rest of the article.

About the author

VT

Jeffry John Aufderheide is the father of a child injured as a result of vaccination. As editor of the website www.vactruth.com he promotes well-educated pediatricians, informed consent, and full disclosure and accountability of adverse reactions to vaccines.